Letter of the Central Staff Committee to the President of the EPO

EPO’s Central Staff Committee reports on arbitrary reallocation of patent applications from IPQC companies. Here is the statement of companies involved: IPQC cannot comment on EPO internal proceedings. IPQC member companies explicitly reject and do not tolerate any form of special treatment of its European patent applications by the EPO. Rather, IPQC repeats its request […]